Ionis Pharmaceuticals (IONS) PT Raised to $115 at Barclays
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $76.37 +0.63%
Rating Summary:
19 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
19 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
Barclays analyst Eliana Merle raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $115.00 (from $106.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Outdoor Holding (POWW) PT Raised to $2.75 at Roth/MKM, reiterates Top Pick
- Southwest (LUV) PT Raised to $61 at UBS Ahead of Q2 Print
- Ralliant Corp. (RAL) PT Raised to $85 at Morgan Stanley: 'organic pathway to sustained HSD into 2027'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
